PREPARED FOR
Chitosan Global
commercial team,
formulators & prospective
B2B buyers.
SCOPE
Carboxymethyl chitosan,
chitosan hydrochloride, COS
lactate, quaternary chitosan.
Scientific evidence, material comparisons, and formulation implications distinguishing what the literature supports from what it merely suggests.
CARBOXYMETHYL CHITOSAN • CMCS
The strongest oral-care signal in the chitosan family
Peer-reviewed work concentrates on two mechanisms: biofilm interference against Streptococcus mutans and biomimetic remineralization of dentin & enamel.
MECHANISM 01
Biofilm interference & S. mutans suppression
CMCS / amorphous-calcium-phosphate nanocomplexes reduce oral bacterial adherence and biofilm formation on human enamel.
Narrative and systematic reviews report that chitosan polymers inhibit S. mutans biofilm formation and acid production the cariogenic mechanism that drives caries onset.
MECHANISM 02
Enamel & dentin remineralization platform
CMCS stabilizes amorphous calcium phosphate and templates intrafibrillar mineralization of demineralized dentin lesions.
Experimental resins releasing CMCS sustain Ca & P delivery, supporting remineralization of early caries positioning CMCS as a fluoride-adjacent or fluoride-alternative platform under study.
FORMULATION FIT
Water-soluble, mucoadhesive, gel-ready
The carboxymethyl substitution gives CMCS true aqueous solubility at near-neutral pH unlike native chitosan, which needs acid activation.
That property is what makes CMCS the form most often recommended for toothpaste gels, mouthwashes, and oral-delivery systems.
MUSHROOM / FUNGAL SOURCE
A positioning advantage — not a clinical one
Fungal-source chitosan supports non-shellfish & hypoallergenic labelling, vegan-compatible procurement, and ESG sourcing but is not, on its own, evidence of superior oral-care efficacy.
WHAT IT EARNS YOU
Defensible label & channel access
01 Non-shellfish, hypoallergenic positioning. Oyster-mushroom mycelium origin removes the crustacean-allergen flag that gates shellfish-derived chitosan in oral products.
02 Vegan-compatible procurement. Zero-animal-input chain qualifies for plant-based and ESG-aligned retail listings.
03 Batch uniformity. Fermentation-controlled mycelium yields a cleaner molecular profile than seasonally-varying shellfish chitin.
WHAT IT DOES NOT EARN
A claim of superior oral efficacy
Published comparative studies in the cited oral-care literature do not isolate fungal vs. shellfish chitosan as the variable driving biofilm inhibition or remineralization outcomes.
The mechanistic actors are well-documented degree of deacetylation, molecular weight, salt form, and derivative chemistry (CMCS, COS, quaternary). Source matters for positioning; chemistry matters for performance.
Recommendation: sell mushroom-source on label / allergen / sustainability terms keep efficacy claims tied to the derivative, not the origin.
FOUR GRADES • ONE DECISION FRAMEWORK
Which chitosan belongs in which oral-care formulation
| ATTRIBUTE | DERIVATIVE 01
Carboxymethyl chitosan |
DERIVATIVE 02
Chitosan hydrochloride |
DERIVATIVE 03
COS lactate |
DERIVATIVE 04
Quaternary chitosan |
| CHEMISTRY | Anionic / amphoteric carboxymethyl-substituted chitosan | HCl-salt of chitosan; cationic in protonated form | Lactate salt of low-MW chitosan oligosaccharide (<3,000 Da) | Quaternary-ammonium-grafted chitosan — permanent cation |
| SOLUBILITY | Water-soluble at near-neutral pH — gel-ready | Water-soluble; well suited to mouthwash & rinse vehicles | Complete water solubility, neutral–slightly acidic; no acid activation | Fully water-soluble across a wide pH range incl. physiological |
| CHARGE BEHAVIOUR | pH-dependent; amphoteric — interacts with Ca²⁺ & mineral phases | Cationic only when amino groups are protonated (acidic-leaning pH) | Cationic; supplier-page +60 mV zeta claim (≥95% DDA, >99% purity) | Permanently cationic — activity persists at neutral / physiological pH |
| STRONGEST EVIDENCED ROLE | Biofilm interference & remineralization in dentin/enamel models | Vehicle / mouthwash & oral-delivery base — water-soluble carrier | Cationic membrane-disruption mechanism; product-page claim, not isolated oral RCT | Broad-pH antimicrobial systems, hydrogels & surface coatings |
| DEPLOY IN | Remineralizing toothpaste gels, anti-caries adjuncts, sensitivity formulations | Mouthwashes, rinses, dissolvable oral films, soluble dispersions | Clean-label preservative & mild-acid oral vehicles where lactate counterion is preferred | Sustained-release antimicrobial coatings, dental-device finishes, hydrogel carriers |
Decision rule · Match the derivative to the dose form:
CMCS → gel/paste · HCl → rinse · COS lactate → mild-acid clean-label · Quaternary → durable cationic surface activity.
WHAT THE EVIDENCE ACTUALLY SUPPORTS
Two industry claims — graded against the literature
Buyers and formulators repeatedly ask about two specific claims. Here is the conservative read.
SUPPORTED
CLAIM · 01
“Quaternary chitosan delivers permanent cationic, broad-pH antimicrobial activity.”
Quaternization grafts a permanent positive charge onto the chitosan backbone, decoupling cationic antimicrobial activity from protonation. The polymer therefore remains active in neutral and physiological pH environments where native chitosan loses charge.
Evidence read. Peer-reviewed work on quaternized chitosan (MDPI Polymers 13(15) 2514; PMC9014838) documents superior water solubility, augmented antimicrobial activity, and broad-pH performance the strongest mechanistic basis among the four derivatives reviewed.
[5] MDPI Polymers 13(15) 2514 [6] PMC9014838 chitosanglobal.com/quaternary-chitosan…
SUPPLIER DATA • USE WITH CARE
CLAIM · 02
“COS lactate carries a +60 mV zeta potential driving its antimicrobial mechanism.”
The cationic membrane-disruption model is well-established in the broader chitosan literature. The specific “+60 mV” figure, however, originates on the Chitonova-60 FG product page (≥95% DDA, >99% purity, ~+50 to +70 mV stated range).
Discipline. Reference the +60 mV value as a supplier specification for the Chitonova-60 FG grade, not as a generalized claim for “chitosan oligosaccharide.” Pair it with cited mechanism literature; do not present it as an independently-validated oral-care RCT endpoint.
chitosanglobal.com/product/chitonova-60-fg • mechanism context: PMC4264197, PMC12537699
THE FOUR-LINE TAKE-AWAY
Match the derivative to the dose form
01. CMCS
Lead with biofilm interference + remineralization. The mechanism most peer-reviewed work actually supports.
02. Mushroom source
Sell on label, allergen, vegan, and ESG terms never as a clinical efficacy claim.
03. HCl & COS lactate
Water-soluble carriers for rinses & clean-label oral vehicles; +60 mV is a Chitonova-60 FG spec, not a category claim.
04. Quaternary chitosan
Best-supported broad-pH, permanently cationic platform surface, coating, and hydrogel applications.
DIRECT CONTACT
Steve Nice
EMAIL & WHATSAPP
steve@chitosanglobal.com
WhatsApp · 01-423-202-6145